TS Investment
VC Fund
Seoul, South Korea
TS Investment is an investment company.
- Total investments:
- 102
- Last investment:
- Lead investor:
- 14%
Last updated:
For AI agents: llms.txt
Industries TS Investment invests in
Stages TS Investment invests in
Countries TS Investment invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
4 more contacts available
Round size
- Series A
- $1.7M–$16M
- Series B
- $5.4M–$22M
Investment Focus
Industry
- Health Care 20 (20%)
- Manufacturing 17 (17%)
- Medical 14 (14%)
- Biotechnology 14 (14%)
- Pharmaceutical 14 (14%)
Stage
- Funding Round 48 (47%)
- Series A 20 (20%)
- Series B 17 (17%)
- Venture - Series Unknown 5 (5%)
- Series C 4 (4%)
Country
- South Korea 88 (86%)
- Singapore 1 (1%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Song Ha-yeon
Team Leader
|
Team Leader | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Data Alliance
|
Data Alliance is an AI infrastructure company providing GPU cloud services through a distributed computing platform. It enables businesses and researchers to access scalable, high-performance computing resources for AI model training, data processing, and advanced analytics, helping reduce costs and accelerate development of machine learning andAI-driven applications. | $2.1M / Seed / Jan 11, 2026 | |
mangrove
|
mangrove is a real estate and rental services provider. | $8.9M / Series B / Dec 03, 2025 | |
Senko Co
|
Senko Co is a maker of electrochemical gas sensor and module, gas detector, odor monitoring system, environmental & breath IoT, etc. | $4.2M / Venture - Series Unknown / Oct 21, 2025 | |
The Hyoosik
|
The Hyoosik is a business specializing in the small and medium-sized lodging. | $14.3M / Series B / Aug 26, 2025 | |
Nex Eye
|
Nex Eye is an innovative biotechnology firm that offers revolutionary immunotherapy solutions for individuals battling cancer. The company addresses the fundamental reasons behind the failure of immunotherapy, which are influenced by the biology of cancer itself. Utilizing its ON-SMRT® platform based on actual patient data and resistant cancermodels, Nex Eye identifies new immune-evasion targets such as ONCOKINE®. By transforming the approach to tackling immune resistance, the firm is pioneering a new era in cancer therapy by revitalizing the capabilities of the immune system. | $44.2M / Series B / Aug 13, 2025 | |
Banban Taxi
|
Banban Taxi is a taxi-booking app that offers ride-hailing, AI-optimized matching, fare-splitting, and loyalty points. The company provides personalized mobility that fits perfectly with granular call product options. Banban Taxi operates taxi and designated driver services and garnered attention as a platform that connects passengers with matchingorigins and destinations for ride-sharing. | $9.5M / Series B / Jul 24, 2025 | |
Illimis Therapeutics
|
Illimis Therapeutics is a platform-based biotech company that develops a chimeric fusion protein platform for neurodegenerative diseases. The company's proprietary GAIA (Gas6-mediated Anti-Inflammatory Adaptor) platform is designed to harness the therapeutic potential of TAM (Tyro3, Axl, Mer) receptor biology, a critical pathway involved inregulating inflammation and immune responses. | $41.9M / Series B / Jul 14, 2025 | |
Acon3D
|
Acon3D is an online 3D model marketplace. | $8.2M / Series A / May 07, 2025 | |
Connecteve
|
Connective is a robotics company that develops artificial intelligence-based artificial joint surgery robots. | $9.7M / Series A / Feb 19, 2025 | |
MOERS
|
MOERS specializes in the development of haptic sports games based on sports simulators and amusement games. | $1M / Series B / Feb 12, 2025 | |
| See all 102 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does TS Investment invest in?
TS Investment invests primarily in Health Care, Manufacturing and Medical startups, most often at Funding Round and Series A stage. Most of the 102 investments tracked by Shizune back companies in South Korea. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is TS Investment's check size?
TS Investment typically joins rounds of $1.7M–$16M at Series A and $5.4M–$22M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds TS Investment participates in.
How do I contact TS Investment?
Public channels for TS Investment include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at TS Investment?
The team at TS Investment includes Song Ha-yeon (Team Leader). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
